阿托伐他汀对慢性心力衰竭患者血清脑钠肽水平及心功能的影响

王自毫, 蔡忠平, 黄永智

王自毫, 蔡忠平, 黄永智. 阿托伐他汀对慢性心力衰竭患者血清脑钠肽水平及心功能的影响[J]. 实用临床医药杂志, 2013, (13): 87-89. DOI: 10.7619/jcmp.201313031
引用本文: 王自毫, 蔡忠平, 黄永智. 阿托伐他汀对慢性心力衰竭患者血清脑钠肽水平及心功能的影响[J]. 实用临床医药杂志, 2013, (13): 87-89. DOI: 10.7619/jcmp.201313031
WANG Zihao, CAI Zhongping, HUANG Yongzhi. Effect of atorvastatin on BNP and cardiac function in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2013, (13): 87-89. DOI: 10.7619/jcmp.201313031
Citation: WANG Zihao, CAI Zhongping, HUANG Yongzhi. Effect of atorvastatin on BNP and cardiac function in patients with chronic heart failure[J]. Journal of Clinical Medicine in Practice, 2013, (13): 87-89. DOI: 10.7619/jcmp.201313031

阿托伐他汀对慢性心力衰竭患者血清脑钠肽水平及心功能的影响

详细信息
  • 中图分类号: R541.6

Effect of atorvastatin on BNP and cardiac function in patients with chronic heart failure

  • 摘要: 目的 探讨阿托伐他汀对慢性心力衰竭(CHF)患者血清脑钠肽(BNP)水平及心功能的影响.方法 将95例CHF患者随机分为治疗组和对照组.对照组给予常规ACEI、地高辛等基础治疗;治疗组进一步随机分为A、B、C共3个组,均在对照组基础上分别加用不同剂量的阿托伐他汀.治疗前及治疗后6、12周检测所有患者的左心室射血分数(LVEF)和血浆BNP浓度.结果 与对照组比较,治疗组BNP下降水平和LVEF上升水平均更为显著(P<0.05);治疗后6周,B、C组血浆BNP水平及LVEF均较A组显著降低(P<0.05),但B、C组血浆BNP水平及LVEF经比较无显著差异(P>0.05);治疗后12周,A、B、C组BNP水平及LVEF与同组治疗后第6周比较均无显著差异(P>0.05).结论 阿托伐他汀能明显降低CHF患者血浆BNP水平,改善LVEF,有利于CHF患者心功能的改善.
  • 胡大一, 杨振华. B型钠尿肽的临床应用和最新进展 [M]. 北京:北京科学技术出版社, 2006.29.
    Lainchbury J G, Campbell E, Frampton C M. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath [J]. Journal of the American College of Cardiology, 2003(4):728.
    Taiara S, Eiiaaf M, Mikhailidis D P. Early vascular benefits ofstatin therapy [J]. Current Medical Research and Opinion, 2003(8):540.
    Maisel A, Krishnsaweng P, Nowake R. Rapid measurement of B-type Natriuretic in the emergency diagnosis of heart failure [J]. Nen-glJ, 2002, (347):161.
    G Galasko, R Senior. What is the most useful and cost-effective strategy to screen for left ventrieular systolic dysfunction in clinical practice [J]. Heart Journal, 2006, (11):1383.
    Maisel A S, Krishnaswamy P, Nowak R M. Rapid measurement of B-type natriurtie peptide in the emergency diagnosis of heart failure [J]. New England Journal of Medicine, 2002(3):161.
    康海, 杨军, 方毅民. 大剂量阿托伐他汀对急性心肌梗死患者心室重构的远期影响 [J]. 中国急救医学, 2008(2):131.doi: 10.3969/j.issn.1002-1949.2008.02.012.
    肖祥彬, 程希富. 他汀类药物在心血管疾病中应用的研究进展 [J]. 心血管病学进展, 2008(4):647.doi: 10.3969/j.issn.1004-3934.2008.04.042.
    Node K, Fujitam, Kitakazem. Short term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy [J]. Circulation, 2003.859.
    Horwich T B, Maclellan W R, Fonarow G C. Stalin therapy is associated with improved survival in isehemic and non-ischemic heart failure [J]. J Am Coil Cardio1, 2004(4):642.
    刘歆, 王燕, 蔡尚郎. 阿托伐他汀对充血性心力衰竭患者心功能和C反应蛋白的影响 [J]. 山东医药, 2007(7):35.doi: 10.3969/j.issn.1002-266X.2007.07.018.
    Kim J, Washio T, Yamagishi M. A novel data mining approach to the identification of effective drugs or combinations for targeted endpoints-application to chronic heart failure as a new form of evidence-based medicine [J]. Cardiovase Drugs Tber, 2004(6):483.
    Crilley J G, Farter M. Left ventricular remodeling and brain natriuretic peptide after first myocardial infarction [J]. Heart, 2001(6):638.
计量
  • 文章访问数:  220
  • HTML全文浏览量:  43
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 发布日期:  2013-10-15

目录

    /

    返回文章
    返回
    x 关闭 永久关闭